Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir
media
posted on 2021-06-11, 13:49 authored by Adis Rapid Journals on behalf of:, Alessio Aghemo, Yves Horsmans, Stefan Bourgeois, Mark Bondin, Michael Gschwantler, Harald Hofer, Nasser Semmo, Francesco Negro, Zhenzhen Zhang, John Marcinak, Ella Veitsman, Rawi Hazzan, Konstantinos Mimidis, Ioannis Goulis, Nuno Marques, Robert Flisiak, Wlodzimierz Mazur, Carlos Roncero, Fiona Marra, Georges Philippe Pageaux, Tarik Asselah, Pietro Lamperticot<p><strong>Article full
text</strong></p>
<p><br></p><p>
The above summary slide represents the opinions of
the <b>authors</b>. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC <b>2021.</b></p>
